Literature DB >> 12058964

Expression of Ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells.

Jane M Barrett1, Mark A Puglia, Gurmit Singh, Richard G Tozer.   

Abstract

The expression levels of ets and MMP genes was examined in two breast cancer cell lines of differing invasive potential. The more invasive MDA-MB-231 cell line had higher levels of Ets-1, Ets-2, PEA3, ERM, Tel, Net, MMP-13 and -14 mRNA than MCF-7 cells. MMP-1, -3 and -16 mRNAs were expressed equally. TPA stimulated MMP-1, -9 and TIMP-1 mRNA expression in both cell lines. MMP-2 and MMP-7 mRNAs were not detected in either cell line. The Ets-1 protein was only detected in MDA-MB-231 cells and its level increased following TPA stimulation. TPA induced MMP-9 activity in MCF-7 cells and increased its activity in MDA-MB-231 cells, however, MMP-2 activity was not detected.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12058964     DOI: 10.1023/a:1014993006190

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  8 in total

1.  Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells.

Authors:  Andreas M Stark; Bartosz Anuszkiewicz; Rolf Mentlein; Toshiyuki Yoneda; H Maximilian Mehdorn; Janka Held-Feindt
Journal:  J Neurooncol       Date:  2006-07-19       Impact factor: 4.130

2.  CDK7-dependent transcriptional addiction in triple-negative breast cancer.

Authors:  Yubao Wang; Tinghu Zhang; Nicholas Kwiatkowski; Brian J Abraham; Tong Ihn Lee; Shaozhen Xie; Haluk Yuzugullu; Thanh Von; Heyuan Li; Ziao Lin; Daniel G Stover; Elgene Lim; Zhigang C Wang; J Dirk Iglehart; Richard A Young; Nathanael S Gray; Jean J Zhao
Journal:  Cell       Date:  2015-09-24       Impact factor: 41.582

3.  In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.

Authors:  Larisa M Haupt; Erik W Thompson; Ann E O Trezise; Rachel E Irving; Michael G Irving; Lyn R Griffiths
Journal:  BMC Cancer       Date:  2006-01-24       Impact factor: 4.430

4.  ETS1 Suppresses Tumorigenesis of Human Breast Cancer via Trans-Activation of Canonical Tumor Suppressor Genes.

Authors:  Gi-Cheon Kim; Choong-Gu Lee; Ravi Verma; Dipayan Rudra; Taemook Kim; Keunsoo Kang; Jong Hee Nam; Young Kim; Sin-Hyeog Im; Ho-Keun Kwon
Journal:  Front Oncol       Date:  2020-05-14       Impact factor: 6.244

5.  Pea3 transcription factors and wnt1-induced mouse mammary neoplasia.

Authors:  Rebecca Baker; Claire V Kent; Rachel A Silbermann; John A Hassell; Lawrence J T Young; Louise R Howe
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

6.  Negative regulation of fibroblast growth factor 10 (FGF-10) by polyoma enhancer activator 3 (PEA3).

Authors:  Athina-Myrto Chioni; Richard Grose
Journal:  Eur J Cell Biol       Date:  2009-05-02       Impact factor: 4.492

7.  Transcription factor Ets1 cooperates with estrogen receptor α to stimulate estradiol-dependent growth in breast cancer cells and tumors.

Authors:  Brian T Kalet; Sara R Anglin; Anne Handschy; Liza E O'Donoghue; Charles Halsey; Laura Chubb; Christopher Korch; Dawn L Duval
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

8.  Copper (II) and 2,2'-bipyridine complexation improves chemopreventive effects of naringenin against breast tumor cells.

Authors:  Júlio César Conceição Filho; André Lúcio Franceschini Sarria; Amanda Blanque Becceneri; Angelina Maria Fuzer; Jaqueline Raquel Batalhão; Caio Marcio Paranhos da Silva; Rose Maria Carlos; Paulo Cezar Vieira; João Batista Fernandes; Márcia Regina Cominetti
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.